Peimisine

Peimisine
Product Name Peimisine
CAS No.: 19773-24-1
Catalog No.: CFN98144
Molecular Formula: C27H41NO3
Molecular Weight: 427.62 g/mol
Purity: >=98%
Type of Compound: Alkaloids
Physical Desc.: Powder
Targets: NO | SOD | Calcium Channel
Source: The bulbs of Fritillaria cirrhosa
Solvent: Chloroform, Dichloromethane, Ethyl Acetate, DMSO, Acetone, etc.
Price: $288/20mg
Peimisine may have antihypertensive action, it can inhibit angiotensin I converting enzyme activity in a dose-dependent manner(the IC50 value of 526.5 microM). Peimisine can affect M-receptor, excit β-receptor, restrain the release of internal calcium, and promote to releaseing nitrogen monoxidum in order to relax tracheal smooth muscle and relieve asthma. It plays a protective role against LPS-induced acute lung injury, and against the experimental hepatic fibrosis formation.
Inquire / Order: manager@chemfaces.com
Technical Inquiries: service@chemfaces.com
Tel: +86-27-84237783
Fax: +86-27-84254680

Address:
1 Building, No. 83, CheCheng Rd., Wuhan Economic and Technological Development Zone, Wuhan, Hubei 430056, PRC
Providing storage is as stated on the product vial and the vial is kept tightly sealed, the product can be stored for up to 24 months(2-8C).

Wherever possible, you should prepare and use solutions on the same day. However, if you need to make up stock solutions in advance, we recommend that you store the solution as aliquots in tightly sealed vials at -20C. Generally, these will be useable for up to two weeks. Before use, and prior to opening the vial we recommend that you allow your product to equilibrate to room temperature for at least 1 hour.

Need more advice on solubility, usage and handling? Please email to: service@chemfaces.com

The packaging of the product may have turned upside down during transportation, resulting in the natural compounds adhering to the neck or cap of the vial. take the vial out of its packaging and gently shake to let the compounds fall to the bottom of the vial. for liquid products, centrifuge at 200-500 RPM to gather the liquid at the bottom of the vial. try to avoid loss or contamination during handling.
  • Molecules.2022, 27(13):4227.
  • QASCF2022, 14(4).
  • Invest New Drugs.2017, 35(2):166-179
  • Biochem Pharmacol. 2023, 210:115463.
  • Nutrients.2024, 16(7):965.
  • Pharmaceuticals (Basel).2020, 13(10):302.
  • J.of Traditional&Complementary Med.2022, 10.1016:j.jtcme.
  • Pharmaceuticals (Basel).2021, 14(7):633.
  • Phytochem Anal.2023, pca.3305.
  • Foods.2022, 12(1):136.
  • Peimisine

    Catalog No: CFN98144
    CAS No: 19773-24-1
    Price: $288/20mg
    Veratramine

    Catalog No: CFN90929
    CAS No: 60-70-8
    Price: $40/20mg
    Veratrosine

    Catalog No: CFN93067
    CAS No: 475-00-3
    Price: Inquiry(manager@chemfaces.com)
    Solasodine

    Catalog No: CFN90200
    CAS No: 126-17-0
    Price: $168/20mg
    Solasonine

    Catalog No: CFN90156
    CAS No: 19121-58-5
    Price: $168/20mg
    Solamargine

    Catalog No: CFN90159
    CAS No: 20311-51-7
    Price: $118/20mg
    Khasianine

    Catalog No: CFN90387
    CAS No: 32449-98-2
    Price: $168/20mg
    Beta-Solamarine

    Catalog No: CFN90552
    CAS No: 3671-38-3
    Price: Inquiry(manager@chemfaces.com)
    Solasurine

    Catalog No: CFN90553
    CAS No: 27028-76-8
    Price: Inquiry(manager@chemfaces.com)
    Solamarine

    Catalog No: CFN93102
    CAS No: 20318-30-3
    Price: Inquiry(manager@chemfaces.com)
    Chinese Traditional & Herbal Drugs, 2009, 40(4):597-601.
    Antiasthmatic mechanism of peimisine in Fritillaria monantha.[Reference: WebLink]
    To approach the antiasthmatic mechanism of Peimisine in Fritillaria monatha.
    METHODS AND RESULTS:
    To observe the effect of Peimisine in the different concentration on the tracheal smooth muscle contraction in vitro organ induced by Ach, His, β-receptor, CaCl 2, Pro, in nitricoxide synthase catastaltica. Peimisine (0.046 and 0.092 mmol/L) made the EC 50 induced by Ach increased; The EC 50 of peimsine (0.092 mmol/L) was not changed by His; The EC 50 of Peimisine (0.092 mmol/L) was not significantly different to tracheal smooth muscle contraction induced by CaCl 2; Three dosages of Peimisine had significant inhibition on the release of intracellular calcium induced by CaCl 2 (P < 0.05, 0.01, and 0.001) in a dose-dependent manner. But extracellular calcium influx was not significantly inhibited. Comparing with the L-NAME+dissolvant group, three dosages of Peimisine couldn't restrain the contraction and had no significant difference.
    CONCLUSIONS:
    Peimisine could affect M-receptor, excit β-receptor, restrain the release of internal calcium, and promote to releaseing nitrogen monoxidum in order to relax tracheal smooth muscle and relieve asthma.
    Lishizhen Medicine & Materia Medica Research, 2014, 8(13-14):1842-7.
    Peimisine attenuates acute lung injury induced by lipopolysaccharide in mice[Reference: WebLink]
    To determine the protective effect of Peimisine on acute lung injury( ALI) induced by lipopolysaccharide( LPS) and its protective mechanism mice.
    METHODS AND RESULTS:
    The mice were randomly allocated into sham,LPS and Peimisine + LPS groups. The ALI mice was induced by LPS after etherization. The Peimisine was injected by belly cavity 30 minutes prior to the LPS challenge,one time/d,3 times totally. The mice were killed 24h after the third Peimisine injection to observe the amount of LDH,MDA in plasma,the lung tissue pathology,the total protein,white blood cell and differential count in the bronchoalveolar lavage fluid( BALF). LDH,MDA amount in plasma,Lung tissue,and BALF showed serious inflammatory changes in the LPS group. Compared with the LPS group,Peimisine attenuates Lung tissue injury,LDH and MDA amount in ALI mice in a dose dependent manner. Peimisine( 0. 12mg) lowered the total protein,total white blood cells,lymphocyte and neutrophilic leukocyte in BALF compared with the LPS group.
    CONCLUSIONS:
    Peimisine can play a protective role against LPS-induced acute lung injury.
    Chinese Traditional & Herbal Drugs, 2013, 44(11):1455-9.
    Protection of peimisine on hepatic fibrosis of rats induced by CCl4.[Reference: WebLink]
    To investigate the protective effect of Peimisine on carbon tetrachloride(CCl4)-induced hepatic fibrosis in rats.
    METHODS AND RESULTS:
    The rats were divided into control,model,low-,mid-,and high-dose(2.5,5,and 10 mg/kg) Peimisine groups.Hepatic fibrosis models were induced by ip injection of CCl4 in rats once every 3 d for 8 weeks.The rats in the treatment groups were administered four weeks after the model establishment,once daily until the end of the week 4 after the model establishment.The levels of serum alanine aminotransferase(ALT),aspartate aminotransferase(AST),alkaline phosphatase(ALP),glutamyl transpeptidasecc(GGT),hyaluronie acid(HA),laminin(LN),type III procollagenc(PC-III),and collegen type IV(IV-C) were assayed,and hepatic tissue contents of hydroxyprolinc(Hyp),superoxide dismutase(SOD),and malondialdehyde(MDA) were determined.The effect of Peimisine on hepatic fibrosis in rats was observed. Compared with the model control group,the hepatic fibrosis of rats in Peimisine groups was improved obviously,the levels of ALT,AST,ALP,and GGT in serum were lowered obviously(P 0.05,0.01),also the serum levels of HA,LN,PC-III,IV-C,and the contents of Hyp and MDA in liver tissue were decreased(P 0.01),while the level of SOD was increased(P 0.01).
    CONCLUSIONS:
    Peimisine has the protective effect on the experimental hepatic fibrosis formation.The possible mechanisms are associated with inhibiting fibrogenesis and fibrosis accumulation,and decreasing lipid peroxidation.
    Planta Med. 2003 Jun;69(6):564-5.
    Angiotensin converting enzyme (ACE) inhibitory alkaloids from Fritillaria ussuriensis.[Pubmed: 12865981 ]
    Bioassay-guided fractionation of the BuOH-soluble extract of Fritillaria ussuriensis afforded verticinone ( 1), verticine ( 2), and Peimisine ( 3). Purification of these compounds was achieved with the use of various chromatographic methods.
    METHODS AND RESULTS:
    The structures of the compounds were identified on the basis of MS and NMR data analysis. Compounds 1 - 3 inhibited angiotensin I converting enzyme activity in a dose-dependent manner, displaying 50 % inhibitory concentration values of 165.0 microM, 312.8 microM, 526.5 microM, respectively.
    CONCLUSIONS:
    The presence of these active substances may be responsible, at least in part, for the antihypertensive action of the bulbs of Fritillaria ussuriensis.
    3'-Methoxymirificin

    Catalog No: CFN95112
    CAS No: 1297609-29-0
    Price: $318/5mg
    Cistantubuloside C1

    Catalog No: CFN95121
    CAS No: 620632-36-2
    Price: $298/10mg
    3-O-[5'''-O-feruloyl-beta-D-apiofuranosyl(1'''->2'')-beta-D-glucopyranosyl] rhamnocitrin

    Catalog No: CFN95154
    CAS No: 148210-00-8
    Price: $413/5mg
    Astin B

    Catalog No: CFN95188
    CAS No: 151201-76-2
    Price: $318/10mg
    9,11-Dehydro-beta-boswellic acid

    Catalog No: CFN95335
    CAS No: 471-65-8
    Price: $318/5mg
    Hydroxytyrosol 1-O-glucoside

    Catalog No: CFN95367
    CAS No: 76873-99-9
    Price: $318/10mg
    Oblongaroside B

    Catalog No: CFN95543
    CAS No: 1000889-11-1
    Price: $318/10mg
    Methyl lucidenate E2

    Catalog No: CFN95569
    CAS No: 98665-12-4
    Price: $413/5mg
    Tectorigenin 7-O-gentiobioside

    Catalog No: CFN95577
    CAS No: 67604-94-8
    Price: $318/5mg
    Mahuannin E

    Catalog No: CFN95585
    CAS No: 1173887-70-1
    Price: $318/5mg